Skip to content
★ Sign in to follow
Total declarations
3
Company
1
▲ Purchases (2 ops.)
€116k
▼ Sales (0 ops.)
—

Latest filing published 28 Jun 2023 for Natco Pharma Limited.

Filing timeline

BuySale
V C Nannapaneni

V C Nannapaneni: trading record in brief

V C Nannapaneni appears in our data through filings on Natco Pharma Limited shares, published by SEBI (PIT + SAST). Over a trading history stretching from 30 November 2022 to 26 June 2023, the count stands at 3 filings.

On the market, this insider has only ever bought: 2 purchases, €116k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The newest entry dates from 28 June 2023: a transaction, in Natco Pharma Limited. The clock since the last published purchase (20 December 2022) now reads 1,419 days. The median gap between a trade and its publication by SEBI (PIT + SAST) is 1 day. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.

Companies and markets linked to V C Nannapaneni

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    ExecutivesNatco Pharma Limited
    2SEBI
    5,440,045 sharesEquity SharesSEBI:43a727b0154da983fb82dc4bfbf2a2fb54391d21
    Canonical exit: 24 Sept 2023 (T+90)
  • ▲
    ExecutivesNatco Pharma Limited
    5M INR7SEBI
    9,050 shares@ ₹550.802349.0% of flowEquity SharesSEBI:8033d0342d238c563f36bfd577c2ac7be7fd3712
    Canonical exit: 19 Mar 2023 (T+90)
  • ▲
    ExecutivesNatco Pharma Limited
    5M INR7SEBI
    8,880 shares@ ₹562.154551.0% of flowEquity SharesSEBI:598f991e4394b267762f4642c8632548568e61a0
    Canonical exit: 28 Feb 2023 (T+90)

3 of 3 declarations